Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
TGFBI encodes an RGD-containing protein that binds to type I, II and IV collagens. Additionally we are shipping Transforming Growth Factor, beta-Induced, 68kDa Kits (36) and Transforming Growth Factor, beta-Induced, 68kDa Proteins (10) and many more products for this protein.
Showing 10 out of 102 products:
Human Polyclonal TGFBI Primary Antibody for IHC, IHC (p) - ABIN4284120
Kashyap, Harsha, Renuse, Pawar, Sahasrabuddhe, Kim, Marimuthu, Keerthikumar, Muthusamy, Kandasamy, Subbannayya, Prasad, Mahmood, Chaerkady, Meltzer, Kumar, Rustgi, Pandey: SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome. in Cancer biology & therapy 2011
Show all 3 references for 4284120
Human Polyclonal TGFBI Primary Antibody for EIA, WB - ABIN955176
Edelstein, Huang, Harocopos, Waltman: Genotype of lattice corneal dystrophy (R124C mutation in TGFBI) in a patient presenting with features of avellino corneal dystrophy. in Cornea 2010
Show all 3 references for 955176
Human Polyclonal TGFBI Primary Antibody for ELISA, IHC - ABIN4284118
Zenteno, Correa-Gomez, Santacruz-Valdez, Suarez-Sanchez, Villanueva-Mendoza: Clinical and genetic features of TGFBI-linked corneal dystrophies in Mexican population: description of novel mutations and novel genotype-phenotype correlations. in Experimental eye research 2009
Human Polyclonal TGFBI Primary Antibody for ELISA, WB - ABIN563175
Han, Sim, Vora, Huang: A unique TGFBI protein in granular corneal dystrophy types 1 and 2. in Current eye research 2012
downregulation of CSD2 (show TGFB1 Antibodies) by the heat-inducible miR398 is required for thermotolerance in Arabidopsis.
Data indicate that in the MKK5 (show MAP2K5 Antibodies)-RNAi (RNA interference) lines, the induction of CSD1 and CSD2 (show TGFB1 Antibodies) as well as the activation of MKK5 (show MAP2K5 Antibodies) activity were completely arrested.
Data indicate that transgenic plants expressing miR398-resistant forms of CSD1, CSD2 (show TGFB1 Antibodies) and CCS (show CCS Antibodies) under the control of their native promoters are more sensitive to heat stress.
miR398 links expression of the three major chloroplast copper proteins, plastocyanin, CCS1 and Csd2 (show TGFB1 Antibodies), to copper availability.
CSD2 (show TGFB1 Antibodies) expression is fine-tuned by miR398-directed mRNA cleavage.
Results show that CSD1, but not CSD2 (show TGFB1 Antibodies), mRNA levels were negatively correlated with miR398 levels during ozone, salinity and biotic stress.
Data suggest that big-h3 protein (BIGH3 (show TGFB1 Antibodies)) acts as a tumor suppressor in the retina.
TGF-beta (show TGFB1 Antibodies)-induced matricellular protein-null lungs displayed diminished elastic recoil and gas exchange efficiency
the data suggest a model by which cytokine-induced Myt3 suppression leads to Tgfbi de-repression and subsequently to impaired islet-cell migration, revealing a novel role for Myt3 in regulating islet-cell migration.
Studies reveal that growth hormone (GH (show GH1 Antibodies))increases TGFBI (show TGFB1 Antibodies) expression in a mouse and rat models of diabetic nephropathy (DN) which correlate with clinical results, and suggest that this mechanism can explain the podocytes depletion in DN.
Tgfbi (show TGFB1 Antibodies) deficiency is associated with the degradation of cartilage matrix
The results support a novel inflammatory pathway for diabetic retinopathy. This pathway is initiated by TGFbeta (show TGFB1 Antibodies) released from macrophages, which promotes synthesis and release of BIGH3 (show TGFB1 Antibodies) protein by REC (show ZDHHC2 Antibodies) and REC (show ZDHHC2 Antibodies) apoptosis.
TGFBI (show TGFB1 Antibodies) is a potential risk gene for human diabetes.
High blood TGFBIp levels were observed in cecal ligation and puncture (CLP)-induced septic mice. The absence of the TGFBIp gene in mice attenuated CLP-induced sepsis.
Collectively, our findings indicate that betaig-h3 (show TGFB1 Antibodies) promotes the fibrogenic influence of TGFbeta (show TGFB1 Antibodies) signaling, neutralizing the prochondrogenic influence of the hypoxic-inducible factor 1 activated by the microenvironment of limb mesenchymal aggregates.
the observed effect of TGFBI (show TGFB1 Antibodies) on bone mass and bone size was largely caused by the effect of TGFBI (show TGFB1 Antibodies) on periosteal bone formation
This study shows that upregulation of bigh3 and bambia mRNA correlated with the process of fin regeneration and regulation of TGF-b signaling, suggesting a new role for these proteins.
Results describe the distribution of TGFBI (show TGFB1 Antibodies) in the developing skeletal muscle of zebrafish embryos, and use antisense morpholino oligonucleotides to investigate the function of the endogenous protein.
The p.(Val113Ile) mutation results in an alteration of the atypical LCD phenotype associated with the p.(Leu558Pro) mutation. This represents only the second report of the alteration of the phenotype of a TGFBI dystrophy by a second, non-homozygous pathogenic mutation, and thus provides insight into the phenotype-genotype correlation of the TGFBI dystrophies.
Our findings demonstrate that granular corneal dystrophy type 1 may present with a vortex pattern of anterior stromal deposits. Although this pattern of dystrophic deposits is not recognized by clinicians as a typical phenotype of GCD1, it is consistent with the production of the majority of the TGFBI protein by the corneal epithelium.
The right cornea showed a higher number of lattice lines than the left cornea. Molecular analysis involving bidirectional complete sequencing demonstrated a novel T621P mutation in exon 14 of TGFBI.
ig-h3, Peroxiredoxin-2 (show PRDX2 Antibodies), and NRF2 (show GABPA Antibodies) have roles in cervical carcinogenesis
LASIK surgery of granular corneal dystrophy type 2 patients leads to accumulation and differential proteolytic processing TGFBI protein.
High TGFBI expression in Esophageal squamous cell carcinoma is associated with hematogenous recurrence.
We observed that knockdown of Cul4A (show CUL4A Antibodies) was associated with increased sensitivity to gemcitabine through upregulation of TGFBI in lung cancer cells.
TGFBIp expression is positively regulated by TGF-beta1 (show TGFB1 Antibodies) in corneal fibroblasts, whereas TGF-beta1 (show TGFB1 Antibodies)-induced miR (show MLXIP Antibodies)-21 and miR (show MLXIP Antibodies)-181a negatively regulate TGFBIp expression.
Data suggest that periostin (show POSTN Antibodies) and TGFBI (transforming growth factor-beta induced protein) can be considered paralogs in some ways: structural homology, phylogeny, and functions in extracellular matrix formation/cell adhesion/cellular immunity. [REVIEW]
No mutations were detected in the TGFBI gene in Korean patients with macular corneal dystrophy.
This gene encodes an RGD-containing protein that binds to type I, II and IV collagens. The RGD motif is found in many extracellular matrix proteins modulating cell adhesion and serves as a ligand recognition sequence for several integrins. This protein plays a role in cell-collagen interactions and may be involved in endochondrial bone formation in cartilage. The protein is induced by transforming growth factor-beta and acts to inhibit cell adhesion. Mutations in this gene are associated with multiple types of corneal dystrophy.
, transforming growth factor, beta induced, 68 kDa
, transforming growth factor-beta-induced protein ig-h3
, RGD-containing collagen-associated protein
, Transforming growth factor-beta-induced protein ig-h3
, transforming growth factor induced protein